Longevity and healthspan have emerged rapidly as an increasingly serious category of healthcare study and investment. But there are a lot of ideas inside the industry and out about exactly what the goal is. Is it about extending lifespans as much as possible? Are we trying to live forever? Or do we just want to experience less physical and cognitive decline as we age?

In today’s episode of the pharmaphorum podcast, host Jonah Comstock speaks with Boyang Wang, the founder of Immortal Dragons, a $40 million Singapore-based fund focusing exclusively on moonshot longevity innovations.

In a broad-ranging conversation, they talk about popular misconceptions about the longevity space and why it’s something that everyone should care about. They talk a bit about specific areas of investment for Immortal Dragons like organ synthesis and gene therapy. And they try to look ahead into the future of a space which is all about getting us to that future alive and well.